In This Section

CICR Steering Committee

Lori S. Friedman, PhD
Chair

Lori S. Friedman, PhD

(2024-2026)

Chief Scientific Oficer
ORIC Pharmaceuticals, Inc.
San Francisco, California

Mary M. Mader, PhD
Immediate Past-Chair

Mary M. Mader, PhD

(2024-2025)

Vice-President
Molecular Innovation
Indiana Biosciences Research Institute
Indianapolis, Indiana

Sara Buhrlage, PhD

Sara Buhrlage, PhD

(2022-2025)

Associate Professor
Cancer Biology, Dana-Farber Cancer Institute
Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Boston, Massachusetts

Elisabetta Chiarparin, PhD

Elisabetta Chiarparin, PhD

(2024-2027)

Senior Vice President
Head of Discovery and Development Technologies
Merck Healthcare KGaA
Darmstadt, Germany

Clara Christ, PhD

Clara Christ, PhD

(2024-2027)

Head of Molecular Design
Bayer Senior Science Fellow
Bayer AG
Berlin, Germany

Danette L. Daniels, PhD

Danette L. Daniels, PhD

(2022-2025)

Vice-President
Protein Degrader Platform
Foghorn Therapeutics
Cambridge, Massachusetts

Erin F. DiMauro, PhD

Erin F. DiMauro, PhD

(2024-2027)

Erin F. DiMauro, Ph.D.
Executive Director, Discovery Chemistry
Merck & Co., Inc.
Rahway, New Jersey

Katherine A. Donovan, PhD

Katherine A. Donovan, PhD

(2024-2027)

Lead Scientist & Managing Director, Fischer labs
Cancer Biology, Dana-Farber Cancer Institute
Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Boston, Massachusetts

Lawrence Hamann, PhD

Lawrence Hamann, PhD

(2023-2026)

President
Chief Executive Officer
Interdict Bio
San Francisco, California

Katrina Jackson, PhD

Katrina Jackson, PhD

(2023-2026)

Senior Director
C4 Therapeutics
Watertown, Massachusetts

Daniel La, PhD

Daniel La, PhD

(2023-2026)

Vice President
Triana Biomedicines
Lexington, Massachusetts

Daniel K. Nomura, PhD

Daniel K. Nomura, PhD

(2022-2025)

Professor of Chemical Biology
Department of Chemistry
University of California, Berkeley
Berkeley, California

Jennifer C. Petter, PhD

Jennifer C. Petter, PhD

(2022-2025)

Founder and Chief Innovation Officer
Arrakis Therapeutics
Waltham, Massachusetts

Monica Schenone, PhD

Monica Schenone, PhD

(2023-2026)

Head of Chemical Biology East Coast
Pfizer Inc.
Cambridge, Massachusetts

Hong Shen, PhD

Hong Shen, PhD

(2022-2025)

Head of China Innovation Center of RocheSenior Vice President
Shanghai, China

Frederic Zecri, PhD

Frederic Zecri, PhD

(2023-2026)

Global Head Oncology and Immuno-Oncology Chemistry
Novartis Institutes for BioMedical Research (NIBR)
Brookline, Massachusetts